Mar­tin Shkre­li re­ceives life­time in­dus­try ban, forced to re­turn al­most $65M in prof­its af­ter an­ti­com­pet­i­tive scheme

Mar­tin Shkre­li will have to find a new nick­name.

A fed­er­al judge banned the for­mer biotech CEO and “Phar­ma Bro” from the drug in­dus­try on Fri­day, or­der­ing him to pay near­ly $65 mil­lion in il­lic­it prof­its. Shkre­li was con­vict­ed of se­cu­ri­ties fraud in 2017 and is cur­rent­ly serv­ing a sev­en-year prison sen­tence, though he orig­i­nal­ly gained no­to­ri­ety for rais­ing the price of the an­tipar­a­sitic drug Dara­prim from $13.50 to $750 in 2015.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER